Fernando Sabino, MD, PhD (@fsabino_onco) 's Twitter Profile
Fernando Sabino, MD, PhD

@fsabino_onco

Medical Oncologist at Hospital Sírio-Libanês, Brazil. GU & GI tumors. Co-founder Brazilian Information in Oncology (BIO). Maratonist & Triathlete (3 x IronMan).

ID: 1202907680588914689

calendar_today06-12-2019 11:08:47

723 Tweet

768 Followers

433 Following

Fernando Sabino, MD, PhD (@fsabino_onco) 's Twitter Profile Photo
Fernando Sabino, MD, PhD
@fsabino_onco

2 years ago

Congrats to Neeraj Agarwal, MD, FASCO for the interesting data and presentation of TALAPRO-2 trial. Talazoparib + Enzalutamide improve rPFS regardless HRR status. However OS benefit is pending and toxicity is a critical issue (72% G3/4 AE, 19% treatment discontinuation)… BIO - Brazilian Information Oncology #GU23

Congrats to <a href="/neerajaiims/">Neeraj Agarwal, MD, FASCO</a> for the interesting data and presentation of TALAPRO-2 trial. Talazoparib + Enzalutamide improve rPFS regardless HRR status. However OS benefit is pending and toxicity is a critical issue (72% G3/4 AE, 19% treatment discontinuation)… <a href="/OncologyBio/">BIO - Brazilian Information Oncology</a> #GU23